D
ABBV icon

Diversified’s AbbVie ABBV Stock Holding History

Diversified’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.38M Sell
6,972
-74
-1% -$13.8K 0.15% 61
2024
Q2 		$1.21M Buy
7,046
+782
+12% +$130K 0.14% 61
2024
Q1 		$1.14M Buy
6,264
+152
+2% +$26.2K 0.16% 42
2023
Q4 		$947K Sell
6,112
-497
-8% -$72.5K 0.21% 46
2023
Q3 		$985K Sell
6,609
-224
-3% -$32.9K 0.26% 42
2023
Q2 		$921K Sell
6,833
-132
-2% -$19.4K 0.23% 45
2023
Q1 		$1.11M Sell
6,965
-393
-5% -$60.1K 0.4% 33
2022
Q4 		$1.19M Buy
7,358
+1,222
+20% +$187K 0.47% 33
2022
Q3 		$824K Buy
6,136
+3,238
+112% +$465K 0.42% 34
2022
Q2 		$444K Sell
2,898
-101
-3% -$15.4K 0.18% 60
2022
Q1 		$486K Sell
2,999
-162
-5% -$23.5K 0.2% 69
2021
Q4 		$428K Buy
3,161
+2
+0.1% +$236 0.18% 73
2021
Q3 		$341K Buy
3,159
+2
+0.1% +$229 0.18% 76
2021
Q2 		$356K Buy
3,157
+849
+37% +$95.6K 0.2% 71
2021
Q1 		$250K Buy
2,308
+23
+1% +$2.46K 0.19% 81
2020
Q4 		$200K Buy
+2,285
New +$220K 0.17% 88

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Diversified's ABBV Position: Q3 2024 in Review

Diversified reduced its AbbVie (ABBV) stake by 1.1% in Q3 2024, selling an estimated $13.8K and leaving 6,972 shares worth $1.38M. The position accounts for 0.15% of the portfolio, ranked #61.

Diversified first reported a position in ABBV in Q4 2020 and has held it in 16 quarters since. 3,500 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

  • Diversified held 6,972 shares of AbbVie worth $1.38M as of Q3 2024.
  • Diversified sold 74 AbbVie shares in Q3 2024, an estimated $13.8K.
  • AbbVie made up 0.15% of Diversified's portfolio in Q3 2024, its #61 holding.
  • Diversified first reported a position in AbbVie in Q4 2020 and has held it in 16 quarters since.
  • 3,500 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on Diversified's 13F filing for Q3 2024, filed 13 Nov 2024.